Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the Optimal Biopsy Scheme at MRI Target Biopsy

NCT04183699 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04183699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04183699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the Optimal Biopsy Scheme at MRI Target Biopsy
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Terminated
Start date
June 6, 2019
Completion date
June 3, 2026
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suspicion of prostate cancer with a positive multiparametric magnetic resonance of the prostate